News


All series


All News

Heidelberg Engineering GmbH recently launched two new products, OCT2, the next generation OCT module for Spectralis diagnostic imaging, and the Heyex picture archiving and communication system (PACS).

There is no question that certain vision care plans have dominated the eyecare market for the last two decades. Nearly 100 million Americans are covered by just two of these plans. As they have become dominant and integrated into new lines of business, they increasingly are coercing optometrists, ophthalmologists, independent laboratories, and consumers-the result higher, prices less choice, and reduced competition.

Genetic testing in AMD is a relatively new focus for optometrists and an important one to ensure that we are getting a complete view of our patients’ risk for developing advanced AMD. Although we are making some progress, we still have work to do to gain a better understanding of how to incorporate its use into clinical practice.

A recent report from business research firm IBISWorld ranked optometry as one of the top industries for women. The firm analyzed data from the Bureau of Labor Statistics and a database of more than 700 industry reports to identify six industries that offer unique employment advantages for women, characterized by strong growth in revenue and employment, particularly in the number of female workers.

The International Classification of Diseases, 10th Edition (ICD-10) code is scheduled for implementation in the U.S. on Oct. 1, 2015-less than a year from now. Many optometric practices will likely be unprepared and therefore at risk for serious claim-filing and cash flow problems, according to Rebecca Wartman, OD, the American Optometric Association's (AOA) point person on ICD-10.

Most of us would probably say that the vast majority of our patients are quite satisfied with the care they receive in our offices. But how do we know this for sure?

In his second installment for his Optometry Times blog, The Schachter Factor, Dr. Scott Schachter discusses his protocol for diagnosing and treating dry eye patients in his practice.

Ohr Pharmaceutical recently announced details of the planned Phase III registration trials for squalamine eye drops (OHR-102) in the treatment of wet age-related macular degeneration (AMD), which are being designed based on guidance provided by the U.S. Food and Drug Administration (FDA) at a recent "end of Phase II" meeting.

I recently read that the restaurant in Tampa, which licenses the name Hogan’s Beach from the professional wrestler Hulk Hogan, is under fire for its controversial dress code. One area of concern for us optometrist is the fourth item on this controversial dress code: “No excessively baggy attire.” You may be questioning how this is germane to comanagement or, frankly, what this has to do with the doctoring of the eyes.

When the retina in my left eye detached in early October 2013, I was on a tour bus, somewhere between Canter’s Deli and Griffith Observatory, in Los Angeles. There was a series of flashes, like warning flares, and then a black tide, an oil slick of a blind spot that started down and to the left and crept toward the center of my vision, arcs of lightning heralding its advance. I knew what was happening, but I didn’t want to believe it.

Alcon recently launched Toric Pro, a new app that gives cataract surgeons a number of tools in a single app intended to improve their knowledge on toric IOL procedures for treating astigmatism at the time of surgery.

Reichert Technologies recently released the new Xcel 455 Slit Lamp, a traditional style slit lamp with tower illumination and five-step magnification.

A recent study from researchers at Tel Aviv University published in Vision Research found that a test examining involuntary eye movements may help diagnose attention deficit/hyperactive disorder (ADHD) and can predict whether stimulant medication would be an effective treatment for the individual.